PSI
IONS icon

Planning Strategies Inc.’s Ionis Pharmaceuticals IONS Stock Holding History

Planning Strategies Inc.’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$634 Buy
+8
New +$602 ﹤0.01% 816

Other funds holding IONS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
WMA
West Michigan Advisors Holland, Michigan $455M AUM 31.82% 1-Year Est. Return

Planning Strategies Inc.'s IONS Position: Q2 2026 in Review

Planning Strategies Inc. opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 8 shares worth $634. The stake represents ﹤0.01% of the portfolio and ranks #816 among its holdings.

112 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Planning Strategies Inc. held 8 shares of Ionis Pharmaceuticals worth $634 as of Q2 2026.
  • Ionis Pharmaceuticals was a new Planning Strategies Inc. position in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Planning Strategies Inc.'s portfolio in Q2 2026, its #816 holding.
  • 112 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Planning Strategies Inc.'s 13F filing for Q2 2026, filed 27 Jul 2026.